- Home
- RELL vs VRXA Comparison
RELL vs VRXA Comparison
Compare RELL & VRXA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RELL | VRXA |
|---|---|---|
| Founded | 1947 | N/A |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Electronic Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 250.1M | 263.0M |
| IPO Year | 2004 | N/A |
Fundamental Metrics
Financial Performance| Metric | RELL | VRXA |
|---|---|---|
| Price | $19.88 | $1.84 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 358.7K | 257.9K |
| Earning Date | 04-08-2026 | N/A |
| Dividend Yield | ★ 1.75% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $228,564,000.00 | N/A |
| Revenue This Year | $6.32 | N/A |
| Revenue Next Year | $7.91 | N/A |
| P/E Ratio | $230.96 | ★ N/A |
| Revenue Growth | ★ 9.41 | N/A |
| 52 Week Low | $9.37 | $1.70 |
| 52 Week High | $23.15 | $4.50 |
Technical Indicators
Market Signals| Indicator | RELL | VRXA |
|---|---|---|
| Relative Strength Index (RSI) | 55.03 | 34.60 |
| Support Level | $15.05 | $1.74 |
| Resistance Level | $23.15 | $2.29 |
| Average True Range (ATR) | 1.73 | 0.18 |
| MACD | 0.20 | 0.05 |
| Stochastic Oscillator | 50.30 | 16.98 |
Price Performance
Historical ComparisonAbout RELL Richardson Electronics Ltd.
Richardson Electronics Ltd provides engineered solutions, power grid, and microwave tubes and related consumables, power conversion, RF and microwave components, high-value flat panel detector solutions, replacement parts, tubes, and service training for diagnostic imaging equipment and customized display solutions. The company's segment includes Power and Microwave Technologies, Green Energy Solutions, Canvys, and Healthcare. The company generates the majority of its revenue from the Power and Microwave Technologies segment, which includes the power grid and microwave tube business and RF, Wireless and Power technologies.
About VRXA Veraxa Biotech AG Ordinary Shares
Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.